BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 17967730)

  • 1. A clinical approach to autoantibody testing in systemic autoimmune rheumatic disorders.
    Stinton LM; Fritzler MJ
    Autoimmun Rev; 2007 Nov; 7(1):77-84. PubMed ID: 17967730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-DFS70/LEDGF antibodies are more prevalent in healthy individuals compared to patients with systemic autoimmune rheumatic diseases.
    Mahler M; Parker T; Peebles CL; Andrade LE; Swart A; Carbone Y; Ferguson DJ; Villalta D; Bizzaro N; Hanly JG; Fritzler MJ
    J Rheumatol; 2012 Nov; 39(11):2104-10. PubMed ID: 22942262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of antinuclear antibody titers and patterns by using HEp-2 and primate liver tissue substrate indirect immunofluorescence assay in patients with systemic autoimmune rheumatic diseases.
    Wei Q; Jiang Y; Xie J; Lv Q; Xie Y; Tu L; Xiao M; Wu Z; Gu J
    J Clin Lab Anal; 2020 Dec; 34(12):e23546. PubMed ID: 33047841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of autoantibody testing.
    Aggarwal A
    Best Pract Res Clin Rheumatol; 2014 Dec; 28(6):907-20. PubMed ID: 26096093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Testing for autoimmunity in humans.
    D'Cruz D
    Toxicol Lett; 2002 Feb; 127(1-3):93-100. PubMed ID: 12052646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoantibodies Against DFS70/LEDGF Exclusion Markers for Systemic Autoimmune Rheumatic Diseases (SARD).
    Seelig CA; Bauer O; Seelig HP
    Clin Lab; 2016; 62(4):499-517. PubMed ID: 27215068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of anti-DFS70 antibody in patients with systemic autoimmune rheumatic diseases.
    Peker BO; Şener AG; Tarhan EF; Kaya S
    Clin Rheumatol; 2019 Dec; 38(12):3627-3633. PubMed ID: 31396837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical aspects of autoimmune rheumatic diseases.
    Goldblatt F; O'Neill SG
    Lancet; 2013 Aug; 382(9894):797-808. PubMed ID: 23993190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoantibodies and overlap syndromes in autoimmune rheumatic disease.
    Jury EC; D'Cruz D; Morrow WJ
    J Clin Pathol; 2001 May; 54(5):340-7. PubMed ID: 11328831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging technologies in autoantibody testing for rheumatic diseases.
    Olsen NJ; Choi MY; Fritzler MJ
    Arthritis Res Ther; 2017 Jul; 19(1):172. PubMed ID: 28738887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Laboratory diagnostics in rheumatology].
    Wiik A
    Ugeskr Laeger; 2002 Jan; 164(5):610-4. PubMed ID: 11871209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effective use of autoantibody tests in the diagnosis of systemic autoimmune disease.
    Lyons R; Narain S; Nichols C; Satoh M; Reeves WH
    Ann N Y Acad Sci; 2005 Jun; 1050():217-28. PubMed ID: 16014537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of immunologic testing in suspected rheumatologic disease.
    Bhagat M; Sehra ST; Shahane A; Kwan M
    Curr Allergy Asthma Rep; 2014 Jan; 14(1):405. PubMed ID: 24370946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunological tests in autoimmune rheumatic disease.
    Isenberg DA
    Br J Hosp Med; 1993 Sep 15-Oct 5; 50(6):315-20. PubMed ID: 8242215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of thyroid autoantibodies in patients with systematic autoimmune rheumatic diseases. Cross-sectional study.
    Posselt RT; Coelho VN; Pigozzo DC; Guerrer MI; Fagundes MDC; Nisihara R; Skare TL
    Sao Paulo Med J; 2017; 135(6):535-540. PubMed ID: 29267515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type I interferon in patients with systemic autoimmune rheumatic disease is associated with haematological abnormalities and specific autoantibody profiles.
    Reynolds JA; Briggs TA; Rice GI; Darmalinggam S; Bondet V; Bruce E; Khan M; Haque S; Chinoy H; Herrick AL; McCarthy EM; Zeef L; Hayes A; Duffy D; Parker B; Bruce IN
    Arthritis Res Ther; 2019 Jun; 21(1):147. PubMed ID: 31200750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A study of anti-carbonic anhydrase II antibodies in rheumatic autoimmune diseases.
    Ono M; Ono M; Watanabe K; Miyashita Y; Inagaki Y; Ueki H
    J Dermatol Sci; 1999 Nov; 21(3):183-6. PubMed ID: 10527380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum immunoglobulin free light chain levels in systemic autoimmune rheumatic diseases.
    Gulli F; Napodano C; Marino M; Ciasca G; Pocino K; Basile V; Visentini M; Stefanile A; Todi L; De Spirito M; Rapaccini GL; Basile U
    Clin Exp Immunol; 2020 Feb; 199(2):163-171. PubMed ID: 31618438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoantibody Biomarkers in Rheumatic Diseases.
    Kang EH; Ha YJ; Lee YJ
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32085664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DFS70 Autoantibodies are Rare in Healthy Danish Individuals but may Still Serve as a Diagnostic Aid.
    Nilsson AC; Voss A; Lillevang ST
    Scand J Immunol; 2015 Dec; 82(6):547-8. PubMed ID: 26354722
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.